Julie C Harper MD
`
`The Dermatology and Skin Care Center of Birmingham
`2470 Rocky Ridge Rd
`Birmingham, AL 35243
`Phone (205) 978-3336
`Fax (205) 503-4915
`j uharper@yahoocom
`
`Education:
`
`1987-1991
`
`Southeast Missouri State University
`ES.
`
`1992-1996
`
`University of Missouri-Columbia School of Medicine
`MD.
`
`1 996-1 997
`
`University of Missouri—Columbia
`Internal Medicine Internship
`
`1997-2000
`
`University of Missouri—Columbia
`Dermatology Residency
`
`Academic Appointments:
`
`2007 — Present
`
`The Dermatology and Skin Care Center of Birmingham- Private Practice
`
`2007 — Present
`
`University of Alabama-Birmingham
`Department of Dermatology
`Clinical Associate Professor
`
`2005—2006
`
`University of Alabama-Birmingham
`Department of Dermatology
`Associate Professor
`
`Residency Program Director
`
`2000-2005
`
`University of Alabama-Birmingham
`Department of Dermatology
`Assistant Professor
`
`Assistant Residency Program Director
`
`Certification:
`
`American Board of Dermatology
`October 2000
`
`1 0f 13
`
`Almirall EXHIBIT 2023
`
`Amneal v. Almirall
`IPR2018-00608
`
`

`

`Licensure:
`
`State of Alabama
`
`Hon ors/Awards:
`
`American Academy of Dermatology Presidential Citation Award Recipient
`2016
`Southeast Missouri State University Alumi Merit Award Recipient
`2013
`Alpha Omega Alpha Honor Society
`1996
`1995-96 Medical School Senior Class Vice-President
`
`1996
`1991
`1988
`
`Dermatology Clerkship Award
`Beta Beta Beta Biology Honor Society
`Phi Eta Sigma Freshman Honor Society
`
`Activities:
`
`2017-2019
`2015-2017
`2015-2017
`2013
`
`2012
`2010-2012
`2009-2010
`2008-2009
`2007-2008
`2005-present
`
`2006
`
`2004
`
`2003-2005
`
`2003-2007
`
`2002-present
`2002-2005
`
`2002
`
`2002-2005
`
`2002-2005
`
`2001-2002
`2001-2006
`
`2001
`
`2000-2001
`
`1999
`
`American Acne and Rosacea Society President
`American Acne and Rosacea Society President-Elect
`American Academy of Dermatology Acne Work Group
`CeraVe® National Television Commercial
`
`E3 Medical Mission Trip to Urubamba, Peru
`AAD Private Sector Advocacy Task Force
`President of the Alabama Dermatological Society
`President-Elect of the Alabama Dermatological Society
`Treasurer/Secretary of the Alabama Dermatological Society
`American Acne and Rosacea Society
`Founding Director
`Faculty of 1000
`Faculty contributor
`Practical Dermatology
`Contributing Editor
`American Academy of Dermatology
`Telemedicine Task Force
`Dean’s Council of Graduate Medical Education
`
`Annual Skin Cancer Screening at Dawson Memorial Baptist Church
`American Academy of Dermatology
`Allied Health Professionals Task Force
`
`American Academy of Dermatology Leadership Retreat
`Participant
`UAB Medical Education Committee
`
`Women’s Dermatologic Society
`Chair—website committee
`Medical Education Assessment Committee
`UAB medical student mentor
`
`Women’s Dermatologic Society Board of Directors
`Young Physician Representative
`American Academy of Dermatology
`Telemedicine Task Force
`
`Camp Discovery
`Counselor
`
`20f13
`
`

`

`Publications/Posters:
`
`Hashim PW, Chen T, Harper JC, Kircik LH. The efficacy and safety of azelaic acid 15% foam in the
`treatment of facial acne vulgaris. J Drugs Dermatol 2018, 17(6):641-645.
`
`Harper J C. Use of oral contraceptives for management of acne vulgaris: practical considerations in real
`world practice. Dermatol Clin 2016, 34(2): 159-65.
`
`Zaenglin AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM,
`Harper J C, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Stein Gold LF, Tollefson MM,
`Weiss J S, Dolan NC, Sagan AA, Stern M, Boyer KN, Bhushan R. Guidelines of care for the management
`of acne vulgaris. J Am Acad Dermatol. 2016,74(5):945-73.
`
`Tintle SJ, Harper J C, Webster GF, Kim GK, Thiboutot DM. Safe use of therapeutic dose oral isotretinoin
`in patients with a history of pseudotumor cerebri. JAMA Derm 2016,152(5):582-4.
`
`DelRosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eichenfield LF. Status report from
`the American Acne and Rosacea Society on medical management of acne in adult women, part 3: oral
`therapies. Cutis 2015,96(6):376-82.
`
`DelRosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eichenfield LF. Status report from
`the American Acne and Rosacea Society on medical management of acne in adult women, part 2: topical
`therapies. Cutis 2015,96(5):321-5.
`
`DelRosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eicenfield LF. Status report form the
`American Acne and Rosacea Society on medical management of acne in adult women, part 1: overview,
`clinical characteristics, and laboratory evaluation. Cutis 2015,96(4):236-41.
`
`Draelos ZD, Elewski BE, Harper J C, Sand M, Staedtler G, Nkulikiyinka R, Shakery K. A phase 3
`randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of
`papulopustular rosacea. Cutis. 2015, 96(1):54-61.
`
`McDaniel DH, Hamzavi IH, Zeichner JA, Fabi SG, Bucay VW, Harper J C, Comstock JA, Makino ET,
`Mehta RC, Vega VL. Total Defense + Repair: A Novel Concept in Solar Protection and Skin
`Rejuvenation. J Drugs Dermatol. 2015,14(7):s3-11.
`
`Hudgens S, Harper J C, Daniels SR, Banderas B, Varon S, AleXis AF. Validation of a New Patient-
`Reported Outcome Measure for Facial Acne: The Acne Symptom and Impact Scale (ASIS). J Drugs
`Dermatol. 2015,14(6):552-9.
`
`Harper JC. The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide
`(3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome
`variable. J Drugs Dermatol. 2015,14(4):381-4.
`
`Alexis A, Daniels SR, Johnson N, Pompilus F, Burgess SM, Harper J C. Development of a new patient—
`reported outcome measure for facial acne: the Acne Symptom and Impact Scale (ASIS). J Drugs
`Dermatol. 2014 Mar,13(3):333-40.
`
`Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq Fm Yamasaki K, Harper JC, Del Rosso
`J Q, Gallo RL. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of
`rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013, 69(4):570-7.
`
`30f13
`
`

`

`Dreno B, Layton A, Zouboulis CC, Lopez—Esterbaranz JL, Zalewska—Janowska A, Bagatin E, Zampeli
`VA, Yutskovskaya Y, Harper J C. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol
`2013, 27(9): 1063-70.
`
`Wolverton SE, Harper J C. Important controversies associated with isotretinoin therapy for acne. Am J
`Clin Dermatol. 2013, l4(2):7l-6.
`
`Harper J C. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination
`clindamycin phosphate(l.2%) and benzoyl peroxide (2.5%) aqueous gel. J Drugs Dermatol.
`2012,11(12):1440-5.
`
`Tanghetti E, Harper JC, Oefelein MG The efficacy and tolerability of dapsone 5% gel in female vs male
`patients with facial acne vulgaris: gender as a clinically relevant outcome variable. J Drug Dermatol.
`2012,ll(l2):l4l7—2l.
`
`Harper JC. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed
`combinations. J Drugs Dermatol. 2010,9(5):482-7.
`
`Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther.
`2009,22(5):452-7.
`
`Harper JC. Evaluating hyperandrogenism: a challenge in acne management. J Drugs Dermatol.
`2008,7(6):527-30.
`
`Thiboutot DM, Harper JC, O'Connell K, Rich P, Sondheimer SJ. Improving outcomes through
`collaboration. Cutis. 2008,81(l Suppl):26-3l.
`
`Harper JC. Tailoring individualized treatment plans for acne. Cutis. 2008,81(l Suppl):23-5.
`
`Collier CN, Harper J C, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE. The prevalence of
`acne in adults 20 years and older. J Am Acad Dermatol. 2008 Jan,5 8(1):56-9. Epub 2007 Oct 22. Erratum
`in: J Am Acad Dermatol. 2008 May,58(5):874. Cafardi, JenniferA [added].
`
`Sami N, Harper JC. Topical Retinoids. In Wolverton editor: Comprehensive Dermatologic Drug Therapy
`2nd edition. 2007.
`
`Harper J C. Antiandrogen therapy for skin and hair disease. Dermatol Clin. 2006 Apr,24(2): 137-43, v.
`Review
`
`Harper J. Dermatology. In: Cooper and Pappas editors: Cecil’s Review of General Internal Medicine 8th
`edition. Elsevier Inc. 2005: 893-896
`
`Harper J. The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic
`considerations. Managed Care Interface 2005,18(3):5 1-55.
`
`Harper JC. Hormonal therapy for acne using oral contraceptive pills. Seminars in Cutaneous Medicine
`and Surgery 2005, 24: 103-106.
`
`Harper J. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol.
`2004,5l(Suppl l):S36-S38.
`
`40f13
`
`

`

`Harper J. Propionibacterium acnes: bacterial resistance to antibiotic medications. Infectious Disease in
`Children. Sept 2004: 10-11
`
`Berson D, Chalker D, Harper J, Leyden J, Shalita A Webster G. Current concepts in the treatment of
`acne: report from a clinical roundtable. Cutis 2003: 72(1S):5-15.
`
`Harper J. Acne vulgaris. eMedicine 2002
`
`Harper J. Oral contraceptives for acne: a guide to safety and efficacy. Practical Dermatology. 2004,
`1(2):29-30.
`
`Harper J. A sensible approach to anti-aging therapy in rosacea. Practical Dermatology. 2004, 1(3): 17-18.
`
`Harper J Choosing safe options to manage acne in pregnant women. Practical Dermatology.
`2004,1(4):21—23.
`
`Harper J. Light for acne: present realities and possibilities. Practical Dermatology. 2004, 1(5): 18-19.
`
`Harper J. Environmental factors in acne and rosacea. Practical Dermatology. 2004, 1(6):21-22.
`
`Harper J. Acne and rosacea: no free pass for sun worshippers. Practical Dermatology. 2004,1(7):29-30.
`
`Harper J Diet and Acne: is there a connection. Practical Dermatology. 2004,
`
`1(9):23-24.
`
`Harper J Insight on diagnosing and managing ocular rosacea. Practical Dermatology. 2004,
`30.
`
`1(11):29-
`
`Harper J. A year in review: what 2004 taught us about acne. Practical Dermatology. 2004,
`18.
`
`1(12):17-
`
`Harper J, Thiboutot D. Pathogenesis of acne: recent research advances. In: Yancy editor: Advances in
`Dermatology 2003, 19: 1—10.
`
`Boyce S, Harper J. Paraneoplastic Derrnatoses. In:Callen J, Thiers B, editors. Dermatol Clin 2002;20:523-
`532.
`
`Harper J, Griess T, Hendriks B. DNCB-A Safe Alternative in the Treatment of Warts. Poster March 2001
`AAD.
`
`Presentations:
`
`2018
`
`Laboratory Monitoring for Isotretinoin
`SCALE
`
`Nashville, Tennessee
`
`2018
`
`Hormonal Treatment of Acne and Hirsutism
`
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`50f13
`
`

`

`2018
`
`2018
`
`2018
`
`2018
`
`Prescribing Spironolactone for Acne
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`Treating Acne in Women
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`Acne Boot Camp- Hormonal Therapies
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`Tips for Treating Acne
`Winter Clinical Dermatology Meeting
`Maui, Hawaii
`
`2017
`
`Rosacea
`
`2017
`
`2017
`
`SDEF Las Vegas Dermatology Seminar
`Las Vegas, Nevada
`
`Rosacea Update
`Fall Clinical Dermatology Meeting
`Las Vegas, Nevada
`
`Practical Approaches to Managing Acne— Systemic Medications
`Fall Clinical Dermatology Meeting
`Las Vegas, Nevada
`
`2017
`
`Hormonal Treatments for Women with Acne
`
`Pennsylvania Academy of Dermatology Meeting
`Hershey, Pennsylvania
`
`2017
`
`Isotretinoin Controversies
`
`Pennsylvania Academy of Dermatology Meeting
`Hershey, Pennsylvania
`
`2017
`
`Update on Acne and Rosacea
`Georgia Pearls
`Atlanta, Georgia
`
`2017
`
`Acne Guidelines — Hormonal Treatments
`
`American Academy of Dermatology Summer Meeting
`New York City, New York
`
`2017
`
`2017
`
`Sunscreen
`DERM 2017
`
`Las Vegas, Nevada
`
`Acne Controversies
`SCALE
`
`Nashville, Tennessee
`
`60f13
`
`

`

`2017
`
`2017
`
`2017
`
`2017
`
`2017
`
`Seborrheic Keratoses — Medical and Aesthetic Concerns
`SCALE
`
`Nashville, Tennessee
`
`Emerging Therapies for Atopic Dermatitis
`SCALE
`
`Nashville, Tennessee
`
`Acne Boot Camp- Hormonal Therapies
`American Academy of Dermatology Annual Meeting
`Orlando, Florida
`
`How to Treat Acne in the Pregnant and Nursing Woman
`American Academy of Dermatology Annual Meeting
`Orlando, Florida
`
`Best Approaches to Treating Acne in Women
`American Academy of Dermatology Annual Meeting
`Orlando, Florida
`
`2017
`
`Sunscreen
`
`2017
`
`SDEF Hawaii Dermatology Seminar
`Maui, Hawaii
`
`Acne: Questions of Interest
`SDEF Hawaii Dermatology Seminar
`Maui, Hawaii
`
`2016
`
`Acne in the Adult Female
`
`2016
`
`2016
`
`2016
`
`Rosacea New Developments
`Women’s and Pediatric Dermatology Seminar
`Newport Beach, California
`
`Insights into Acne and Rosacea
`Sunscreen
`DERM 2016
`
`Las Vegas, Nevada
`
`Perspectives on Acne
`Nebraska State Dermatology Society meeting
`Omaha, Nebraska
`
`Post-procedure treatment
`What’s New in Topical Treatments
`SCALE
`
`Nashville, Tennessee
`
`2016
`
`Acne in Women
`
`American Academy of Dermatology Annual Meeting
`Washington DC
`
`2016
`
`Prescribing Spironolactone for Acne
`
`70f13
`
`

`

`American Academy of Dermatology Annual Meeting
`Washington DC
`
`2016
`
`Isotretinoin—should we still worry
`American Academy of Dermatology Annual Meeting
`Washington DC
`
`2016
`
`Practical Cosmeceutical Advice
`
`2016
`
`2015
`
`2015
`
`2015
`
`Perspectives on Acne
`Caribbean Dermatology Symposium
`Grand Cayman, Cayman Islands
`
`Cosmeceuticals 101
`Cosmeceuticals for Rosacea
`
`Orlando Dermatology and Aesthetic and Clinical Conference
`Orlando, Florida
`
`How to Improve Outcomes in Acne
`Fall Clinical Dermatology Conference
`Las Vegas, Nevada
`
`Rosacea Update
`Georgia Dermatology Physician Assistants PEARLS conference
`Atlanta, Georgia
`
`Adult Female Acne
`DERM20 1 5
`
`Las Vegas, Nevada
`
`2015
`
`Acne and Rosacea
`
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`2015
`
`Acne Treatment Controversies
`
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`2015
`
`Practical Guidelines For Using Spironolactone in Acne Patients
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`2015
`
`The Science of Cosmeceuticals and Nutraceuticals
`
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`2015
`
`2015
`
`Dermatologic Drug Safety and Efficacy
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`Translating Evidence into Practice: Acne Guidelines
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`80f13
`
`

`

`2014
`
`Presenter
`
`Sociedade Brasileria de Derrnatologia
`Recife, Brazil
`
`2014
`
`Adult Female Acne
`DERM20 14
`
`Las Vegas, Nevada
`
`2014
`
`Acne Treatment Controversies
`
`2014
`
`2014
`
`2013
`
`2013
`
`American Academy of Dermatology Annual Meeting
`Denver, Colorado
`
`Dermatologic Drug Safety and Efficacy
`American Academy of Dermatology Annual Meeting
`Denver, Colorado
`
`Challenges and Controversies in Acne
`Winter Clinical Dermatology Conference
`Kohala Coast, Hawaii
`
`Treating the Aging Face
`Women’s and Pediatric Dermatology Seminar
`Newport Beach, California
`
`Acne and Rosacea Therapy Pearls
`Southeastern Consortium
`
`Birmingham, Alabama
`
`2013
`
`Acne Treatment Controversies
`
`American Academy of Dermatology Annual Meeting
`Miami, Florida
`
`2013
`
`2013
`
`2012
`
`2012
`
`2012
`
`Acne: An Expert’s Tips
`Caribbean Dermatology Symposium
`Grand Cayman
`
`Rosacea is an Inflammatory Disease
`Caribbean Dermatology Symposium
`Grand Cayman
`
`Acne Vulgaris
`Georgia Dermatology Physician Assistants PEARLS conference
`Atlanta, Georgia
`
`Common Controversies in Dermatologic Drug Therapy
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`Acne & Rosacea Update
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`90f13
`
`

`

`2012
`
`Acne & Rosacea
`
`American Academy of Dermatology Annual Meeting
`San Diego, California
`
`2012
`
`2012
`
`2011
`
`Acne from an Expert
`Hawaii Dermatology Seminar
`Kohala Coast, Hawaii
`
`Rosacea Developments
`Hawaii Dermatology Seminar
`Kohala Coast, Hawaii
`
`Acne Update
`Dermatology Summer Symposium
`Destin, Florida
`
`2011
`
`What’s New in Rosacea
`
`Women’s and Pediatric Dermatology Seminar
`San Francisco, California
`
`2011
`
`Acne in Adult Women
`
`Women’s and Pediatric Dermatology Semina
`San Francisco, California
`
`2011
`
`2011
`
`2010
`
`2010
`
`2010
`
`Controversies in Dermatologic Drug Therapy
`American Academy of Dermatology Annual Meeting
`New Orleans, Louisiana
`
`Acne and Rosacea Update
`American Academy of Dermatology Annual Meeting
`New Orleans, Louisiana
`
`Acne and Rosacea Update
`Director
`
`American Academy of Dermatology Annual Meeting
`Miami, FL
`
`Controversies in Dermatologic Drug Therapy —Presenter
`American Academy of Dermatology Annual Meeting
`Miami, FL
`
`The Newest on Drugs, Diet and Diagnosis of Acne
`Las Vegas Dermatology
`
`2010
`
`Rosacea News
`
`Las Vegas Dermatology
`
`2010
`
`Topical Treatment in Acne and Rosacea
`Alabama Dermatology Society Beach Meeting
`Sandestin, Florida
`
`10 0f 13
`
`

`

`2009
`
`2009
`
`2009
`
`Hormonal Aspects of Acne — Session Director
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`Should Dermatologist Prescribe Hormonal Contraceptives? — Presenter
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`Update on Acne in Females
`Fall Clinical Dermatology Conference
`Las Vegas, Nevada
`
`2008
`
`Presenter
`
`American Academy of Dermatology Annual Meeting
`San Antonio, Texas
`
`2008
`
`Acne Controversies
`
`Society of Pediatric Dermatology Annual Meeting
`Snowbird, Utah
`
`2008
`
`Acne Update
`Intermountain Dermatology meeting
`Sun Valley, Idaho
`
`2007
`
`Presenter
`
`American Academy of Dermatology Annual Meeting
`Washington DC
`
`Community Acquired MRSA
`World Congress of Dermatology
`Buenos Aires, Argentina
`
`Hormonal Influences in Acne Vulgaris
`American Academy of Dermatology Annual Meeting
`San Francisco, California
`
`Acne Symposium-Session Director
`American Academy of Dermatology Summer Meeting
`Chicago, Illinois
`
`An Alternative Approach to Acne Treatment in Women
`Fall Clinical Dermatology Conference
`Las Vegas, Nevada
`
`Hormonal Aspects of Acne Vulgaris
`Hawaii Dermatology
`
`2007
`
`2006
`
`2005
`
`2005
`
`2004
`
`2004
`
`Acne in Women
`
`Jazz Festival Meeting
`New Orleans, Louisiana
`
`11 0f 13
`
`

`

`2004
`
`Acne and Acne Foolers
`
`American Academy of Dermatology Annual Meeting
`Washington, DC
`
`2004
`
`2004
`
`2003
`
`2003
`
`2003
`
`2003
`
`2003
`
`2003
`
`2003
`
`2002
`
`2002
`
`2002
`
`2002
`
`Acne Vulgaris
`Society Dermatology Physician Assistants
`Washington, DC
`
`Acne Vulgaris
`Dermatology Nurse Association
`Orlando, Florida
`
`Hormonal Aspects of Acne
`Indianapolis Basic Science Review Course
`
`What’s New in Acne Vulgaris
`Pacific Dermatology Association
`Las Vegas, Nevada
`
`What’s New in Acne Vulgaris
`Fall Clinical Dermatology Conference
`Las Vegas, Nevada
`
`Retinoids in the Management of Acne Vulgaris
`Hawaii Dermatology
`
`Retinoids in the Management of Acne Vulgaris
`Society of Investigative Dermatology
`Miami, Florida
`
`Acne and Acne Foolers AAD Annual Meeting and Summer Meeting
`San Francisco, California
`
`Chicago, Illinois
`Update on the Pathogenesis and Management of Acne
`American College of Osteopathic Dermatology
`Telluride, Colorado
`
`Update on the Pathogenesis and Management of Acne
`Colorado Dermatologic Society
`
`Cost of Acne Therapy
`Summer AAD
`
`New York, New York
`
`Acne and Acne Foolers AAD Summer Meeting
`New York, New York
`
`Hormonal Aspects of Acne
`Valley of the Sun Conference
`Scottsdale, Arizona
`
`12 0f 13
`
`

`

`Research :
`
`2001
`
`2000
`
`2000
`
`2000
`
`2017
`
`2013
`
`2010—2011
`
`2010—2011
`
`2009
`
`2004
`
`2003
`
`2002
`
`2002
`
`Acne and Acne Foolers AAD Summer Meeting
`Anaheim, California
`
`Dermatology Primer
`Jefferson County Family Practice
`Jefferson County, Alabama
`
`Dermatology Primer
`American College of Physicians Missouri State Meeting
`
`Dermatology Primer
`American College of Physicians Southeast Missouri Chapter
`Cape Girardeau, Missouri
`
`The efficacy and safety of azelaic acid 15% foam in the treatment of
`acne vulgaris- Investigator
`
`A Phase 3 randomized, double-blind, vehicle controlled trial of azelaic
`
`acid foam 15% in the treatment of papulopustular rosacea - Investigator
`
`Evaluation of the cutaneous innate immune and protease responses of
`adults to Azelaic gel (Finacea) - Principal Investigator
`
`A Phase IV, Open—label study evaluating the use of Solodyn
`(Minocycline HCL extended-release tablets), Ziana and Triaz foaming
`cloths as combination acne therapy for potential isotretinoin candidates
`- Principal Investigator
`
`An Open Label, 8-week study to evaluate the efficacy and tolerability of
`MaXClarityII in subjects with acne — Principal Investigator
`
`A 12-week, multicenter, double-blind, randomized, parallel-design
`study of 5% dapsone topical gel and vehicle control in patients with acne
`vulgaris
`
`A phase III Multicenter, randomized, double-blind, active and
`vehicle—controlled study of safety and efficacy of velac gel for the
`treatment of acne vulgaris.
`
`A randomized double—blind, placebo—controlled, multicenter study
`evaluating the efficacy of norgestimate 180-250mcg/EE 25 mcg in
`the treatment of moderate acne vulgaris
`
`A 15 week, randomized, double-blind multicenter study comparing
`the clinical efficacy and safety of azelaic acid 15% gel (SH H 655 BA)
`with metronidazole 0.75 %gel in patients with papulopustular facial
`rosacea
`
`13 0f 13
`
`